Biomaterial: Tissue Regeneration Technologies, LLC

• Publication date: June 2012
• Report size: 23 pages

This report is a source for data, analysis and actionable intelligence on the Tissue Regeneration Technologies, LLC portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover data on product ...

This report is a source for data, analysis and actionable intelligence on the Tissue Regeneration Technologies, LLC portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover data on product description, function, technology, indication, and application. The report is also supplemented with a detailed industry player profile and data on clinical trials, wherever applicable.

Scope of the Research

- Detailed industry player profile with data on business description, key industry player facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the new product development, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional data on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with data on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, industry ing and sales strategies.
- Exploit Merger and Acquisition opportunities by identifying industry players with the most innovative pipeline.
- Develop successful market-entry strategies .
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ new product development through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Biomaterial Industry in the United States

Data table of Contents
Data table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Tissue Regeneration Technologies, LLC - Major Products and Services 5
Tissue Regeneration Technologies, LLC Pipeline Products by Equipment Type 6
Tissue Regeneration Technologies, LLC Pipeline Products by Development Stage 7
Tissue Regeneration Technologies, LLC Pipeline Products by Therapy Area 8
Tissue Regeneration Technologies, LLC Pipeline Products by Trial Phase 9
DermaGold 10
Product Status 10
Product Description 10
Product Milestone 10
DermaGold Clinical Trial 10
OrthoGold 280 12
Product Status 12
Product Description 12
OrthoGold 280 Clinical Trial 12
Tissue Regeneration Technologies, LLC - Top Competitors 15
Tissue Regeneration Technologies, LLC - Key Executives 16
Tissue Regeneration Technologies, LLC - Key Employee Biographies 17
Tissue Regeneration Technologies, LLC - Operations and Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
August 25, 2010: TRT Receives New Patents For Biofilm Elimination And Reproductive Health 19
August 25, 2010: TRT Receives New Patent For Reattaching Soft Tissue To Bone 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20


List of Tables

Tissue Regeneration Technologies, LLC, Major development 1
Tissue Regeneration Technologies, LLC Key Pipeline Products by Equipment Type 1
Tissue Regeneration Technologies, LLC Key Pipeline Products by Therapy Area 1
Tissue Regeneration Technologies, LLC Key Pipeline Products by Development Stage 1
Tissue Regeneration Technologies, LLC Key Pipeline Products by Trial Phase 1
Tissue Regeneration Technologies, LLC, Major development 4
Tissue Regeneration Technologies, LLC, Major Products and Services 5
Tissue Regeneration Technologies, LLC Number of Pipeline Products by Equipment Type 6
Tissue Regeneration Technologies, LLC Pipeline Products by Equipment Type 6
Tissue Regeneration Technologies, LLC Number of Pipeline Products by Development Stage 7
Tissue Regeneration Technologies, LLC Pipeline Products by Development Stage 7
Tissue Regeneration Technologies, LLC Number of Pipeline Products by Therapy Area 8
Tissue Regeneration Technologies, LLC Pipeline Products by Therapy Area 8
Tissue Regeneration Technologies, LLC Number of Pipeline Products by Trial Phase 9
Tissue Regeneration Technologies, LLC Pipeline Products by Trial Phase 9
DermaGold - Product Status 10
DermaGold - Product Description 10
DermaGold - Product Milestone 10
DermaGold - Dermagold Indicated For Use Of Shockwave Treat Of Diabetic Foot Ulcers In Patients With Diabetes Mellitus 10
OrthoGold 280 - Product Status 12
OrthoGold 280 - Product Description 12
OrthoGold 280 - Prospective Randomized Trial of Standard Wound Care Versus Standard Wound Care Plus Shock Wave Therapy for Traumatic Wounds of the Extremity 12
Tissue Regeneration Technologies, LLC, Key Executives 16
Tissue Regeneration Technologies, LLC, Key Employee Biographies 17
Tissue Regeneration Technologies, LLC, Other Locations 18
Tissue Regeneration Technologies, LLC, Subsidiaries 18


List of Figures

Tissue Regeneration Technologies, LLC Pipeline Products by Equipment Type 6
Tissue Regeneration Technologies, LLC Pipeline Products by Development Stage 7
Tissue Regeneration Technologies, LLC Pipeline Products by Therapy Area 8
Tissue Regeneration Technologies, LLC Pipeline Products by Trial Phase 9

Companies mentioned Siemens Healthcare Diagnostics, Inc.
Alpha-Omega Services, Inc.
Direx Systems Corp.